Single Nucleotide Polymorphism in SMAD7 and CHI3L1 and Colorectal Cancer Risk

Table 14

Serum YKL-40 levels (ng/ml) in patients with localized or advanced cancer [201].

Disease	Median serum YKL-40 (ng/l)	Reference
Metastatic breast cancer	80	[209]
CRC	160	[210]
Glioblastoma multiforme	130	[195]
Lower grade gliomas	101
Primary breast cancer	57	[211]
Small cell lung cancer	82	[192]
Local disease	71
Extensive disease	101
Metastatic prostate cancer	112	[208]
Ovarian cancer, all stages	94	[212]
Ovarian cancer, stage III	168
Ovarian cancer, relapse	94